343 related articles for article (PubMed ID: 34761733)
21. Decreased Enteric Bacterial Composition and Diversity in South American Crohn's Disease Vary With the Choice of Treatment Strategy and Time Since Diagnosis.
Cruz-Lebrón A; D'argenio Garcia L; Talla A; Joussef-Piña S; Quiñones-Mateu ME; Sékaly RP; de Carvalho KIL; Levine AD
J Crohns Colitis; 2020 Jul; 14(6):791-800. PubMed ID: 31758685
[TBL] [Abstract][Full Text] [Related]
22. Gut dysbiosis and clinical phases of pancolitis in patients with ulcerative colitis.
Maldonado-Arriaga B; Sandoval-Jiménez S; Rodríguez-Silverio J; Lizeth Alcaráz-Estrada S; Cortés-Espinosa T; Pérez-Cabeza de Vaca R; Licona-Cassani C; Gámez-Valdez JS; Shaw J; Mondragón-Terán P; Hernández-Cortez C; Suárez-Cuenca JA; Castro-Escarpulli G
Microbiologyopen; 2021 Mar; 10(2):e1181. PubMed ID: 33970546
[TBL] [Abstract][Full Text] [Related]
23. Relationship between clinical features and intestinal microbiota in Chinese patients with ulcerative colitis.
He XX; Li YH; Yan PG; Meng XC; Chen CY; Li KM; Li JN
World J Gastroenterol; 2021 Jul; 27(28):4722-4737. PubMed ID: 34366632
[TBL] [Abstract][Full Text] [Related]
24. Deciphering salivary microbiome signature in Crohn's disease patients with different factors contributing to dysbiosis.
Elzayat H; Malik T; Al-Awadhi H; Taha M; Elghazali G; Al-Marzooq F
Sci Rep; 2023 Nov; 13(1):19198. PubMed ID: 37932491
[TBL] [Abstract][Full Text] [Related]
25. Dysbiosis of gut microbiota in inflammatory bowel disease: Current therapies and potential for microbiota-modulating therapeutic approaches.
Alshehri D; Saadah O; Mosli M; Edris S; Alhindi R; Bahieldin A
Bosn J Basic Med Sci; 2021 Jun; 21(3):270-283. PubMed ID: 33052081
[TBL] [Abstract][Full Text] [Related]
26. Fecal microbial dysbiosis in Chinese patients with inflammatory bowel disease.
Ma HQ; Yu TT; Zhao XJ; Zhang Y; Zhang HJ
World J Gastroenterol; 2018 Apr; 24(13):1464-1477. PubMed ID: 29632427
[TBL] [Abstract][Full Text] [Related]
27. Effects of soy milk consumption on gut microbiota, inflammatory markers, and disease severity in patients with ulcerative colitis: a study protocol for a randomized clinical trial.
Sadeghi O; Milajerdi A; Siadat SD; Keshavarz SA; Sima AR; Vahedi H; Adibi P; Esmaillzadeh A
Trials; 2020 Jun; 21(1):565. PubMed ID: 32576228
[TBL] [Abstract][Full Text] [Related]
28. Effect of cinnamon essential oil on gut microbiota in the mouse model of dextran sodium sulfate-induced colitis.
Li AL; Ni WW; Zhang QM; Li Y; Zhang X; Wu HY; Du P; Hou JC; Zhang Y
Microbiol Immunol; 2020 Jan; 64(1):23-32. PubMed ID: 31595527
[TBL] [Abstract][Full Text] [Related]
29. Microbial changes in stool, saliva, serum, and urine before and after anti-TNF-α therapy in patients with inflammatory bowel diseases.
Park YE; Moon HS; Yong D; Seo H; Yang J; Shin TS; Kim YK; Kim JR; Lee YN; Kim YH; Kim JS; Cheon JH
Sci Rep; 2022 Apr; 12(1):6359. PubMed ID: 35428806
[TBL] [Abstract][Full Text] [Related]
30. Functional Characterization of Inflammatory Bowel Disease-Associated Gut Dysbiosis in Gnotobiotic Mice.
Nagao-Kitamoto H; Shreiner AB; Gillilland MG; Kitamoto S; Ishii C; Hirayama A; Kuffa P; El-Zaatari M; Grasberger H; Seekatz AM; Higgins PD; Young VB; Fukuda S; Kao JY; Kamada N
Cell Mol Gastroenterol Hepatol; 2016 Jul; 2(4):468-481. PubMed ID: 27795980
[TBL] [Abstract][Full Text] [Related]
31. Metabarcoding of colonic cleansing fluid reveals unique bacterial members of mucosal microbiota associated with Inflammatory Bowel Disease.
Banzragch M; Sanli K; Stensvold CR; Kurt O; Ari S
Scand J Gastroenterol; 2023; 58(11):1253-1263. PubMed ID: 37337895
[TBL] [Abstract][Full Text] [Related]
32. Increased proportions of Bifidobacterium and the Lactobacillus group and loss of butyrate-producing bacteria in inflammatory bowel disease.
Wang W; Chen L; Zhou R; Wang X; Song L; Huang S; Wang G; Xia B
J Clin Microbiol; 2014 Feb; 52(2):398-406. PubMed ID: 24478468
[TBL] [Abstract][Full Text] [Related]
33. Partners of patients with ulcerative colitis exhibit a biologically relevant dysbiosis in fecal microbial metacommunities.
Chen GL; Zhang Y; Wang WY; Ji XL; Meng F; Xu PS; Yang NM; Ye FQ; Bo XC
World J Gastroenterol; 2017 Jul; 23(25):4624-4631. PubMed ID: 28740351
[TBL] [Abstract][Full Text] [Related]
34. Fecal metabonomics combined with 16S rRNA gene sequencing to analyze the changes of gut microbiota in rats with kidney-yang deficiency syndrome and the intervention effect of You-gui pill.
Chen R; Wang J; Zhan R; Zhang L; Wang X
J Ethnopharmacol; 2019 Nov; 244():112139. PubMed ID: 31401318
[TBL] [Abstract][Full Text] [Related]
35. Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease.
Imhann F; Vich Vila A; Bonder MJ; Fu J; Gevers D; Visschedijk MC; Spekhorst LM; Alberts R; Franke L; van Dullemen HM; Ter Steege RWF; Huttenhower C; Dijkstra G; Xavier RJ; Festen EAM; Wijmenga C; Zhernakova A; Weersma RK
Gut; 2018 Jan; 67(1):108-119. PubMed ID: 27802154
[TBL] [Abstract][Full Text] [Related]
36. Skin microbiota signature distinguishes IBD patients and reflects skin adverse events during anti-TNF therapy.
Reiss Z; Rob F; Kolar M; Schierova D; Kreisinger J; Jackova Z; Roubalova R; Coufal S; Mihula M; Thon T; Bajer L; Novakova M; Vasatko M; Kostovcikova K; Galanova N; Lukas M; Kverka M; Tresnak Hercogova J; Tlaskalova-Hogenova H; Jiraskova Zakostelska Z
Front Cell Infect Microbiol; 2022; 12():1064537. PubMed ID: 36704107
[TBL] [Abstract][Full Text] [Related]
37. Gut microbiota changes in inflammatory bowel diseases and ankylosing spondilytis.
Cardoneanu A; Mihai C; Rezus E; Burlui A; Popa I; Cijevschi Prelipcean C
J Gastrointestin Liver Dis; 2021 Mar; 30(1):46-54. PubMed ID: 33548121
[TBL] [Abstract][Full Text] [Related]
38. Microbial Disruptions in Inflammatory Bowel Disease: A Comparative Analysis.
Ma J; Wang K; Wang J; Zeng Q; Liu K; Zheng S; Chen Y; Yao J
Int J Gen Med; 2024; 17():1355-1367. PubMed ID: 38601196
[TBL] [Abstract][Full Text] [Related]
39. Markers of dysbiosis in patients with ulcerative colitis and Crohn's disease.
Danilova NA; Abdulkhakov SR; Grigoryeva TV; Markelova MI; Vasilyev IY; Boulygina EA; Ardatskaya MD; Pavlenko AV; Tyakht AV; Odintsova AK; Abdulkhakov RA
Ter Arkh; 2019 May; 91(4):17-24. PubMed ID: 31094471
[TBL] [Abstract][Full Text] [Related]
40. Dysbiosis of gut microbiota in patients with neuromyelitis optica spectrum disorders: A cross sectional study.
Shi Z; Qiu Y; Wang J; Fang Y; Zhang Y; Chen H; Du Q; Zhao Z; Yan C; Yang M; Zhou H
J Neuroimmunol; 2020 Feb; 339():577126. PubMed ID: 31841737
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
